Since the WM983B metastatic melanoma cells showed increased BH4 levels and BH4:BH2 ratio when compared to melanocytes, in addition to a higher expression of eNOS and nNOS, we evaluated the effects of GTPCH1 inhibition on DAHP treatment. The gene discussed is NOS1; the disease is melanoma.